Serrao P A, Modanlou H D
Division of Neonatal-Perinatal Medicine, Miller Children's Hospital, University of California-Irvine, Long Beach 90801.
J Perinatol. 1989 Jun;9(2):154-8.
Transcutaneous bilirubin index measurements (TcBI) were determined in ABO-incompatible term white newborn infants who had an indirect Coombs' test for detection of ABO incompatibility (ABO test) performed on cord blood. Serial transcutaneous measurements in the first 72 hours of life in 63 ABO test positive (group I) and 31 ABO test negative (group II) infants were compared with a control group of 109 term ABO compatible infants (group III). During the first phase of this study, the accuracy of TcBI was confirmed in 33 infants who had serum bilirubin determinations demonstrating a correlation coefficient of r = 0.93 between the jaundice meter index reading and total serum bilirubin. Determination of total serum bilirubin using TcBI did not show any statistically significant differences when groups I, II, and III were compared for maximum serum bilirubin values. These results reveal that a positive ABO test does not increase the predictive value of hyperbilirubinemia in ABO-incompatible white newborn infants.
对出生时足月的白人ABO血型不合新生儿进行经皮胆红素指数(TcBI)测量,这些新生儿的脐带血进行了间接抗人球蛋白试验以检测ABO血型不合(ABO试验)。对63例ABO试验阳性(I组)和31例ABO试验阴性(II组)婴儿出生后72小时内的连续经皮测量结果,与109例足月ABO血型相合婴儿的对照组(III组)进行比较。在本研究的第一阶段,对33例婴儿进行血清胆红素测定,证实TcBI的准确性,黄疸仪指数读数与总血清胆红素之间的相关系数r = 0.93。当比较I、II和III组的最大血清胆红素值时,使用TcBI测定总血清胆红素未显示任何统计学上的显著差异。这些结果表明,ABO试验阳性并不会增加ABO血型不合白人新生儿高胆红素血症的预测价值。